Evgeniy B. Shustov

Evgeniy B. Shustov

Auto-generated profile, based on publicly available information

Evgeniy B. Shustov

Golikov Research Clinical Center of Toxicology under the Federal Medical Biological Agency

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2024 in Psychopharmacology and Addiction Biology
Verified
Journal Article
Open access
PDF file
AKAleksey E. Kim
Aleksey E. Kim
ESEvgeny B. Shustov
Evgeny B. Shustov
VGVyacheslav P. Ganapolsky
Vyacheslav P. Ganapolsky
This study revealed the pathogenetic patterns of the development of hypoxic and ischemic disorders in various pathological conditions and substantiated approaches to the use of drugs with antihypoxic activity. The role of the receptor interaction of succinic acid in the composition of succinate-containing antihypoxants with succinate receptor SUCNR1 has been demonstrated. The pharmacodynamic properties of the combined preparation of succinic acid that also contains vitamin precursors of the cofactors of Krebs cycle dehydrogenases nicotinamide (precursor of NAD) and riboflavin mononucleotide (precursor of FAD) and precursor of purine nucleotides (inosine) (cytoflavin) for intravenous drip and oral administration were analyzed. Literature data were also analyzed to evaluate the effectiveness of the use of the metabolic corrector of energy-dependent and hypoxic conditions (cytoflavin) in various central nervous system and cardiovascular diseases. In the case of ischemic disorders of cerebral and coronary blood flow, the effects of the drug are concentrated on the penumbra zone (ischemic penumbra), which is associated with the intravenous administration of the drug to its metabolic activity by influencing endothelial cells, restoring microcirculation, and enhancing the oxygen transport function of the blood. Among the new areas of drug use, the use of cytoflavin in the complex therapy of traumatic brain injuries, traumatic shock, acute respiratory distress syndrome, toxic lesions of the central nervous system, multiple organ failure syndrome, and post-COVID syndrome is promising.

27 April 2024 in Drug development & registration
Verified
Journal Article
Open access
PDF file
YSYuriy Sysoev
Yuriy Sysoev
DSD. D. Shits
D. D. Shits
MPM. M. Puchik
M. M. Puchik
TGT. A. Gutiy
T. A. Gutiy
EFE. V. Fedorova
E. V. Fedorova
SOSergey Okovityi
Sergey Okovityi
Introduction. The naïve Bayes classifier combined with principal component analysis allows to distinguish the effects of antipsychotic agents effectively as well as evaluate their dose-dependency based on their impact on electroencephalogram parameters in rats. Further development of this method requires its validation as an instrument for the screening of new understudied molecules. Valproic acid derivatives appear to be a promising neuropharmacological group as they exhibit not only antiepileptic activity but also mood-stabilizing, antimigraine, neuroprotective and analgesic effects.Aim. This work was carried out to perform the pharmacological screening of a valproic acid aminoester (AVA) that exhibits antidote properties in case of poisoning with anticholinesterase agents.Materials and methods. The experiments were conducted in white outbred rats with chronically implanted electrocorticographic electrodes. AVA was administered at doses of 0,5, 5 and 30 mg/kg. The training set, used as a reference to determine the pharmacological effects of each dose of the investigated substance, included matrixes of effects of 7 drugs: the antiepileptic agent sodium valproate, the D2-dopamine receptor blocker haloperidol, the M-cholinergic receptor blocker tropicamide, the H1-histamine receptor blocker chloropyramine, the acetylcholinesterase inhibitor galantamine, the sedative dexmedetomidine, and the anxiolytic phenazepam.Results and discussion. AVA at the dose of 0,5 mg/kg showed effects similar to those of sodium valproate, while a tenfold dose increase led to the predominance of an atropine-like effect. When administered at the dose of 30 mg/kg, the compound exhibited dexmedetomidine-like action. The central M-anticholinergic effect of AVA was confirmed by an arecoline test in mice, in which the substance at a dose of 88 mg/kg completely abolished the onset of tremor. Dexmedetomidine-like action was cancelled by the administration of atipamezole in equimolar quantities, which may indicate the potential сapability of AVA to activate α2-adrenergic receptors at a high dose. The results of molecular docking suggest that this effect is related specifically to the original aminoester molecule and not to its presumable active metabolites.Сonclusion. The obtained results confirm the effectiveness of the naïve Bayes classifier as an instrument for the prediction of the pharmacological activity of compounds based on their impact on electroencephalogram parameters in rats. Identification of new pharmacological effects of understudied compounds may widen the potential range of their clinical application as well as reveal probable adverse effects.

1 January 2022 in Laboratornye Zhivotnye dlya nauchnych issledovanii (Laboratory Animals for Science)
Verified
Journal Article
Closed access
KSK.M. Shchepetkova
K.M. Shchepetkova
VKVadim A. Kashuro
Vadim A. Kashuro
ESE.B. Shustov
E.B. Shustov
EBEkaterina Gennadjievna Batotsyrenova
Ekaterina Gennadjievna Batotsyrenova
EKE.N. Krasnikova
E.N. Krasnikova
Ртуть относится к числу наиболее опасных тяжелых металлов и представляет серьезную угрозу для здоровья человека. Даже в низких концентрациях ртуть способна повреждать функции многих органов и тканей. Связываясь с SH-группами ферментов, ртуть оказывает ингибирующее действие на их активность, что приводит к избыточному накоплению активных форм кислорода и развитию оксидативного стресса. Окислительно-восстановительный баланс в живом организме поддерживается многоуровневой антиоксидантной системой. Эритроциты защищены от действия активных метаболитов кислорода при помощи различных биологических механизмов, включая воздействие низкомолекулярных антиоксидантов и ферментов. Снижение антиоксидантной способности эритроцитов может повлиять на системную антиоксидантную защиту всего организма. Выяснение механизмов формирования поражений при субхроническом воздействии ртути и ее соединений и фармакологическая коррекция таких нарушений остаются важной проблемой современной медицины. Цель настоящего исследования - изучение влияния фумаровой соли этомерзола на процессы перекисного окисления липидов, параметры антиоксидантной системы эритроцитов крыс при субхроническом низкодозовом воздействии водного раствора ацетата ртути. Субхроническое отравление моделировали путем ежедневного однократного введения водного раствора ацетата ртути в дозе 4 мг/кг крысам линии Вистар, включенным в контрольную и опытную группы. Через 30 дней введения ацетата ртути животных опытной группы делили на 2 подгруппы. В одной подгруппе проводили фармакологическую коррекцию, используя внутрижелудочное введение водного раствора фумаровой соли этомерзола в дозе 12,5 мг/кг в течение 14 дней. Другая подгруппа в те же сроки получала дистиллированную воду. Результаты исследования показали, что введение препарата привело к снижению концентрации диеновых конъюгатов и малонового диальдегида в гемолизате эритроцитов опытной группы крыс. Введение этомерзола фумарата животным опытной группы способствовало снижению активности супероксиддисмутазы, глутатионпероксидазы и глюкозо-6-фосфатдегидрогеназы, а также увеличению активности глутатионтрансферазы. Установлено, что фумаровая соль этомерзола оказывает антиоксидантное действие после субхронического отравления ацетатом...

22 March 2025 in Extreme Medicine
Verified
Journal Article
Open access
PDF file
ESE. B. Shustov
E. B. Shustov
МММ. В. Мельникова
М. В. Мельникова
KMK. V. Masterova
K. V. Masterova
VOV. F. Ostrov
V. F. Ostrov
EZEkaterina Zolotoverkhaja
Ekaterina Zolotoverkhaja
PPP. K. Potapov
P. K. Potapov
Background. The nervous system damage caused by neurotoxicants is characterized by various morphological changes, manifested mainly by dystrophic and necrotic processes. The key mechanisms of post-intoxication asthenia pathogenesis, determined by the specifics of the toxicant, involve activation of apoptosis, trophic disorder, lipid peroxidation (LPO), neuropeptide regulatory insufficiency, as well as cerebrospinal fluid dynamics disorders.Objective. Quantification of the contribution of apoptosis, oxidative stress, and neurotrophin regulation processes to the formation of long-term health consequences of severe acute poisoning with neurotropic toxicants.Material and methods. Experimental studies were performed in male rats. The following toxicants were used: phenylcarbamate (1.6 mg/kg bw), methanol (11.5 g/kg bw), lead acetate (300 mg/kg bw). The period of formation of long-term health effects was 30 days. The level of apoptosis of the brain temporal cortex neurons was evaluated by the TUNEL method. The identification of blood plasma neurospecific proteins was carried out by the ELISA method. Evaluation of LPO and antioxidant system was carried out by standard biochemical methods.Results. Exposure to the substances caused the signs of toxic effects in rats on days 1–2. The maximum severity of poisoning with phenylcarbamate was on the first day, while the maximum severity of poisoning with methanol and lead acetate was manifested on the second day. By days 5–7, the survived animals showed a normalization in the status regardless of the toxicant. On day 30, violations were detected, the totality of which allowed the survived animals to be divided into subgroups according to the manifestation of functional signs of long-term health effects of acute poisoning.Conclusions. The formation of long-term health effects of severe acute poisoning with the studied neurotoxicants was shown to be associated with an increase in the number of TUNEL positive neurons and a decrease in the S100 protein serum concentration. Lipid peroxidation in brain tissues during the specified period did not play a significant role in apoptosis activation.

11 December 2022 in Acta Biomedica Scientifica
Verified
Journal Article
Open access
PDF file
AKA. E. Kim
A. E. Kim
ESE. B. Shustov
E. B. Shustov
ВГВ. П. Ганапольский
В. П. Ганапольский
IZI. P. Zaitseva
I. P. Zaitseva
ALA. V. Lemeshchenko
A. V. Lemeshchenko
Background. A typical extreme factor is hypoxia, which significantly affects the ability to perform tasks of professional activity, in particular, physical activity of various intensity. Physical and neuro-emotional stress under conditions of hypoxia can cause the breakdown of compensatory and adaptive mechanisms with the development of extreme and critical conditions.The aim of the study. Quantitative assessment of the effect of hypoxia on the physical performance of laboratory animals at different levels of their natural resistance.Research methods. Modeling of hypoxia was carried out by the methods of pressure chamber rise of laboratory animals and the administration of a methemoglobin former. Resistance to hypoxic hypoxia was assessed by the criterion of the threshold elevation, to hemic hypoxia – by the lifetime. The criterion for the functional state of laboratory animals was their ability to perform physical activity, which was created by treadmill run or swimming with a load.Results of the study. An altitude of 3500 m causes a decrease in the physical performance of male rats by a third of normoxia level; an altitude of 5000 m – decrease by two times; an altitude of 6500 m – decrease by four times, and at an altitude of 8000 m makes running physical activity by rats impossible. A mild degree of hemic hypoxia causes a decrease in swimming time by almost 2 times, which corresponds to the effect of an altitude of 5000 m on the working capacity; and a moderate degree of hemic hypoxia causes a decrease in swimming time by more than 3 times, which approximately corresponds to the effect of an altitude of 6000 m. The level of resistance to hypoxia has a moderate effect on physical performance, and the factor of a low level of physical performance has almost no effect on the resistance to hypoxia (28 % and 7 % of the trait variability respectively). In animals with an initially low level of resistance to hypoxia, there is also a decrease in working capacity by an average of 20 %.Conclusion. Hemic hypoxia is an adequate model in studies with a complex effect of various extreme factors. Simulation of mild hypoxia caused by the administration of 30 mg/kg of sodium nitrite is an optimal method.

30 October 2023 in Toxicological Review
Verified
Journal Article
Closed access
PDF file
AMAleksandra S. Melekhova
Aleksandra S. Melekhova
ЕШЕвгений Борисович Шустов
Евгений Борисович Шустов
ВЗВероника Николаевна Зорина
Вероника Николаевна Зорина
АБАлександр Яковлевич Беспалов
Александр Яковлевич Беспалов
MMMargarita V. Mel’nIkova
Margarita V. Mel’nIkova
ABAnastasiya A. Bondarenko
Anastasiya A. Bondarenko
Introduction. Despite a significant number of antidotes (atropine, pyridoxine) and anti-seizure drugs in clinical practice (benzodiazepines, barbiturates, valproates, anesthetics), the development of new antidotes for the relief of refractory seizures and recurrence of convulsive syndrome is actual problem. The aim of the work was to study the specific pharmacological activity of a new original derivative of valproic acid in an experiment on models of convulsive syndrome with different mechanisms of action. Material and methods. A comparative study of the effectiveness of the original substance ((1-methylpiperidin-4-yl)-2-propylpentanoate hydrochloride, VAA) was carried out on electroshock, GABA-lytic, catecholamine-dependent seizure models in rats and mice. Results. A significant decrease in seizure activity was revealed in the group with prophylactic administration of VAA in the dose range of 11, 27 and 65 mg/kg in comparison with the control group received only phenylcarbamate. In an intergroup comparison, a low dose (11 mg/kg) more than others had an effect on the latent period of the onset of phenylcarbamate seizures, an average dose (27 mg/kg) reduced the duration of the seizure period, a high dose (65 mg/kg) affected the severity of convulsions, while the integral indicator (convulsive activity) did not differ between the medium and high dose subgroups. There was no significant decrease in seizure activity in models with the use of corazol, camphor, and the model of maximum electric shock. Limitations. Testing of new pharmaceutical substances (study of efficacy and safety) should be carried out on laboratory animals before confirmation of efficacy in humans. The quantity of animals was limited by the need to comply with bioethical principles and sufficient number for statistically significant results and amounted 6 individuals in each group. Conclusion. The release of valproic acid during the metabolism of VAA is slow and its concentration is insufficient to realize the universal anticonvulsant activity of VAA. It is necessary to further study the effect on cognitive functions and neuroprotective properties. Since antidote efficacy superior to atropine has been previously demonstrated, VAA is recommended for development as an antidote for organophosphorus poisoning.